Aura Biosciences (AURA) Return on Capital Employed (2021 - 2026)
Aura Biosciences (AURA) reported Return on Capital Employed of 20.54% for Q1 2026, down 463.0% on a YoY basis from 5.66% in Q1 2025, and down 48.76% quarter-over-quarter from 13.81% in Q4 2025.
Aura Biosciences (AURA) Return on Capital Employed (2021 - 2026) Analysis & Trends
Aura Biosciences has reported Return on Capital Employed for 6 years, with the latest figure at 20.54% in Q1 2026.
- For the quarter ending Q1 2026, Return on Capital Employed fell 463.0% year-over-year to 20.54%; the trailing twelve-month figure through Mar 2026 stood at 20.54% (down 463.0% YoY), and the FY2025 full-year result was 14.14%, down 520.0% from the prior year.
- Return on Capital Employed for Q1 2026 stood at 20.54%, down from 13.81% in the prior quarter.
- The five-year high for Return on Capital Employed was 10.18% in Q4 2024, with the low at 47.23% in Q3 2024.
- Historically, Return on Capital Employed has averaged 30.73% across 5 years, with a median of 34.84% in 2022.
- Annual changes were most pronounced in 2023 — Return on Capital Employed plunged 661 bps — and 2024, when it surged 3126 bps.
- Aura Biosciences' Return on Capital Employed stood at 34.84% in 2022, then decreased by 19 bps to 41.45% in 2023, then surged by 75 bps to 10.18% in 2024, then sank by 36 bps to 13.81% in 2025, then tumbled by 49 bps to 20.54% in 2026.
- The last three Return on Capital Employed figures came in at 20.54% (Q1 2026), 13.81% (Q4 2025), and 19.89% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 450.31% |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | 51.73% |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | -107.40% |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | 21.10% |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | -50.43% |
| 10 | Aura Biosciences | 412.10 Mn | 327.31 Mn | - | -20.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -20.54% |
| Dec 31, 2025 | -13.81% |
| Sep 30, 2025 | -19.89% |
| Jun 30, 2025 | -18.66% |
| Mar 31, 2025 | -15.91% |
| Dec 31, 2024 | -10.18% |
| Sep 30, 2024 | -47.23% |
| Jun 30, 2024 | -41.81% |
| Mar 31, 2024 | -37.33% |
| Dec 31, 2023 | -41.45% |
| Sep 30, 2023 | -44.38% |
| Jun 30, 2023 | -38.53% |
| Mar 31, 2023 | -32.35% |
| Dec 31, 2022 | -34.84% |
| Sep 30, 2022 | -42.06% |
| Jun 30, 2022 | -34.95% |
| Mar 31, 2022 | -28.43% |
| Dec 31, 2021 | -29.87% |